Literature DB >> 27111234

ESAT-6-dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo.

Andreas Kupz, Ulrike Zedler, Manuela Stäber, Carolina Perdomo, Anca Dorhoi, Roland Brosch, Stefan H E Kaufmann.   

Abstract

IFN-γ is a critical mediator of host defense against Mycobacterium tuberculosis (Mtb) infection. Antigen-specific CD4+ T cells have long been regarded as the main producer of IFN-γ in tuberculosis (TB), and CD4+ T cell immunity is the main target of current TB vaccine candidates. However, given the recent failures of such a TB vaccine candidate in clinical trials, strategies to harness CD4-independent mechanisms of protection should be included in future vaccine design. Here, we have reported that noncognate IFN-γ production by Mtb antigen-independent memory CD8+ T cells and NK cells is protective during Mtb infection and evaluated the mechanistic regulation of IFN-γ production by these cells in vivo. Transfer of arenavirus- or protein-specific CD8+ T cells or NK cells reduced the mortality and morbidity rates of mice highly susceptible to TB in an IFN-γ-dependent manner. Secretion of IFN-γ by these cell populations required IL-18, sensing of mycobacterial viability, Mtb protein 6-kDa early secretory antigenic target-mediated (ESAT-6-mediated) cytosolic contact, and activation of NLR family pyrin domain-containing protein 3 (NLRP3) inflammasomes in CD11c+ cell subsets. Neutralization of IL-18 abrogated protection in susceptible recipient mice that had received noncognate cells. Moreover, improved Mycobacterium bovis bacillus Calmette-Guérin (BCG) vaccine-induced protection was lost in the absence of ESAT-6-dependent cytosolic contact. Our findings provide a comprehensive mechanistic framework for antigen-independent IFN-γ secretion in response to Mtb with critical implications for future intervention strategies against TB.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27111234      PMCID: PMC4887189          DOI: 10.1172/JCI84978

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  85 in total

1.  Cutting edge: Enhanced IL-2 signaling can convert self-specific T cell response from tolerance to autoimmunity.

Authors:  Jason Waithman; Thomas Gebhardt; Gayle M Davey; William R Heath; Francis R Carbone
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

Review 2.  Evasion and subversion of antigen presentation by Mycobacterium tuberculosis.

Authors:  A Baena; S A Porcelli
Journal:  Tissue Antigens       Date:  2009-06-25

3.  Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen.

Authors:  H Pircher; K Bürki; R Lang; H Hengartner; R M Zinkernagel
Journal:  Nature       Date:  1989-11-30       Impact factor: 49.962

4.  Identification of nitric oxide synthase as a protective locus against tuberculosis.

Authors:  J D MacMicking; R J North; R LaCourse; J S Mudgett; S K Shah; C F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

Review 5.  Release of mycobacterial antigens.

Authors:  Laleh Majlessi; Rafael Prados-Rosales; Arturo Casadevall; Roland Brosch
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

6.  The Recombinant BCG ΔureC::hly Vaccine Targets the AIM2 Inflammasome to Induce Autophagy and Inflammation.

Authors:  Hiroyuki Saiga; Natalie Nieuwenhuizen; Martin Gengenbacher; Anne-Britta Koehler; Stefanie Schuerer; Pedro Moura-Alves; Ina Wagner; Hans-Joachim Mollenkopf; Anca Dorhoi; Stefan H E Kaufmann
Journal:  J Infect Dis       Date:  2014-12-11       Impact factor: 5.226

7.  Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system.

Authors:  Laleh Majlessi; Priscille Brodin; Roland Brosch; Marie-Jésus Rojas; Huot Khun; Michel Huerre; Stewart T Cole; Claude Leclerc
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

8.  Adoptive transfer of gene-modified primary NK cells can specifically inhibit tumor progression in vivo.

Authors:  Hollie J Pegram; Jacob T Jackson; Mark J Smyth; Michael H Kershaw; Phillip K Darcy
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

9.  Inflammatory monocytes activate memory CD8(+) T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion.

Authors:  Saïdi M'Homa Soudja; Anne L Ruiz; Julien C Marie; Grégoire Lauvau
Journal:  Immunity       Date:  2012-08-30       Impact factor: 31.745

10.  AIM2 Drives Joint Inflammation in a Self-DNA Triggered Model of Chronic Polyarthritis.

Authors:  Christopher Jakobs; Sven Perner; Veit Hornung
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

View more
  28 in total

1.  Mycobacterium tuberculosis PPE60 antigen drives Th1/Th17 responses via Toll-like receptor 2-dependent maturation of dendritic cells.

Authors:  Haibo Su; Zhen Zhang; Zijian Liu; Baozhou Peng; Cong Kong; Honghai Wang; Zhi Zhang; Ying Xu
Journal:  J Biol Chem       Date:  2018-05-08       Impact factor: 5.157

2.  Bacillus Calmette-Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell Responses.

Authors:  Mark Hatherill; Thomas J Scriba; Sara Suliman; Hennie Geldenhuys; John L Johnson; Jane E Hughes; Erica Smit; Melissa Murphy; Asma Toefy; Lesedi Lerumo; Christiaan Hopley; Bernadette Pienaar; Phalkun Chheng; Elisa Nemes; Daniel F Hoft; Willem A Hanekom; W Henry Boom
Journal:  J Immunol       Date:  2016-07-13       Impact factor: 5.422

Review 3.  Macrophage form, function, and phenotype in mycobacterial infection: lessons from tuberculosis and other diseases.

Authors:  Colleen M McClean; David M Tobin
Journal:  Pathog Dis       Date:  2016-07-10       Impact factor: 3.166

Review 4.  MyD88 in Mycobacterium tuberculosis infection.

Authors:  Jorge L Cervantes
Journal:  Med Microbiol Immunol       Date:  2017-02-20       Impact factor: 3.402

Review 5.  Recombinant BCGs for tuberculosis and bladder cancer.

Authors:  Alok K Singh; Geetha Srikrishna; Trinity J Bivalacqua; William R Bishai
Journal:  Vaccine       Date:  2021-09-27       Impact factor: 3.641

Review 6.  ESX secretion systems: mycobacterial evolution to counter host immunity.

Authors:  Matthias I Gröschel; Fadel Sayes; Roxane Simeone; Laleh Majlessi; Roland Brosch
Journal:  Nat Rev Microbiol       Date:  2016-09-26       Impact factor: 60.633

7.  Mucosal delivery of ESX-1-expressing BCG strains provides superior immunity against tuberculosis in murine type 2 diabetes.

Authors:  Harindra D Sathkumara; Visai Muruganandah; Martha M Cooper; Matt A Field; Md Abdul Alim; Roland Brosch; Natkunam Ketheesan; Brenda Govan; Catherine M Rush; Lars Henning; Andreas Kupz
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-10       Impact factor: 11.205

8.  MmpL8MAB controls Mycobacterium abscessus virulence and production of a previously unknown glycolipid family.

Authors:  Violaine Dubois; Albertus Viljoen; Laura Laencina; Vincent Le Moigne; Audrey Bernut; Faustine Dubar; Mickaël Blaise; Jean-Louis Gaillard; Yann Guérardel; Laurent Kremer; Jean-Louis Herrmann; Fabienne Girard-Misguich
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-09       Impact factor: 11.205

Review 9.  Tuberculosis Vaccine Development: Progress in Clinical Evaluation.

Authors:  Suraj B Sable; James E Posey; Thomas J Scriba
Journal:  Clin Microbiol Rev       Date:  2019-10-30       Impact factor: 26.132

10.  IL-1R1-Dependent Signals Improve Control of Cytosolic Virulent Mycobacteria In Vivo.

Authors:  Sanne van der Niet; Maaike van Zon; Karin de Punder; Anita Grootemaat; Sofie Rutten; Simone J C F M Moorlag; Diane Houben; Astrid M van der Sar; Wilbert Bitter; Roland Brosch; Rogelio Hernandez Pando; Maria T Pena; Peter J Peters; Eric A Reits; Katrin D Mayer-Barber; Nicole N van der Wel
Journal:  mSphere       Date:  2021-05-05       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.